A new Periodic Transaction Report filed with the U.S. House of Representatives shows that a dependent child of Hon. April McClain Delaney sold shares of Service Corporation International Common Stock (SCI) on July 20, 2026. The transaction, disclosed under the STOCK Act, falls in the $1,001 to $15,000 range, the standard bracket used for these reports rather than an exact dollar figure.
This is not the first time this particular holding has shown up in Delaney’s disclosures. The same dependent account has reported SCI sales in prior filings, including one covered in our earlier piece, April McClain Delaney’s Dependent Sells More SCI Shares, which tracked a similar transaction just weeks earlier. Taken together, the filings suggest a pattern of incremental sales out of the same SCI position over the summer rather than a single one-off trade.
An Insider Sale on the Same Ticker
What makes this filing notable is its proximity to activity on the corporate insider side. Company insider Faulk John H sold SCI shares on July 31, 2026, in a transaction valued at $1,048,698 according to separate disclosure records. That sale came within roughly ten days of the Delaney dependent’s reported sale, and both fall within the same 30-day window our system uses to flag overlapping congressional and insider activity on a single stock.
It’s worth being clear about what this overlap does and does not show. STOCK Act filings and insider Form 4 disclosures are both routine, legally required reporting mechanisms. Members of Congress and their dependents are required to disclose transactions like this one regardless of size or timing, and the same goes for corporate insiders trading their own company’s stock. The fact that both a congressional filing and an insider sale touched SCI within a short window does not indicate coordination, wrongdoing, or that either party had access to the other’s plans. It simply means two separate reporting obligations produced records that happen to cluster around the same stock and the same few weeks.
Still, for readers tracking SCI-related disclosures, the pattern is useful context. Congressional filings on this ticker have now appeared multiple times in recent weeks, and this latest one arrives alongside a seven-figure insider sale, giving watchers of the stock two independent data points to weigh rather than one. Whether these sales reflect portfolio rebalancing, diversification, or unrelated personal financial decisions is not disclosed in the filings themselves, and this report does not speculate on the reasoning behind either transaction.
As always, readers should treat these disclosures as a transparency measure rather than a signal to act on. The filings tell us that transactions occurred and roughly how large they were, not why they happened or what may come next for the stock.